Prot# NU OL03U3: A Phase II Study of Thalidomide in Combination with Interleukin-2 (IL-2) in Patients with Previously Untreated Metastatic Renal Cell Carcinoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date6/10/0412/22/11

Funding

  • Celgene Corporation (NU OL03U3)